Evaluation of an omega-3 fatty acid supplement in diabetics with microalbuminuria

Annals of the New York Academy of Sciences

Volumn 827, Issue , 1997, Pages 369-381

  Lungershausen, Yvonne K ^a   Howe, Peter R C ^a,f   Clifton, Peter M ^a   Hughes, Christopher R T ^b   Phillips, Pat ^c   Graham, John J ^d   Thomas, David W ^e  

^a CSIRO   (Australia)

^b MODBURY HOSPITAL   (Australia)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

^d Ashford Hospital   (Australia)

^e WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^f UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; FATTY ACID; FISH OIL; LIPID; OMEGA 3 FATTY ACID;

ADULT; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; HUMAN; MALE; MICROALBUMINURIA; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION;

EID: 84950170950     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb51848.x     Document Type: Conference Paper

References (28)

1. EGGERS, P. W. 1988. Effect of transplantation on the Medicare End-Stage Renal Disease Program. N. Engl. J. Med. 318: 223-229.
2. JERUMS, G., M. COOPER, R. GILBERT, R. O'BRIEN & J. TAFT. 1994. Microalbuminuria in diabetes. Med. J. Aust. 161: 265-268.
3. DAMSGAARD, E. M., A. FROLAND, O. D. JORGENSEN & C. E. MOGENSEN. 1990. Microalbuminuria as predictor of increased mortality in elderly people. Br. Med. J. 300: 297-300.
4. BORCH-JOHNSEN, K., H. WENZEL, G. C. VIBERTI & C. E. MOGENSEN. 1993. Is screening and intervention for microalbuminuria worthwhile in patients with insulin-dependent diabetes? Br. Med. J. 306: 1722-1725.
5. ANDERSON, S., H. G. RENNKE, D. L. GARCIA & B. M. BRENNER. 1989. Short- and long-term effects of antihypertensive therapy in the diabetic rat. Kidney Int. 36: 526-536.
6. LEWIS, E. J., L. G. HUNSICKER, R. P. BAIN & R. D. ROHDE. 1993. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329: 1456-1462.
7. MARRE, M., M. HALLAB, A. BILLIARD, J. J. LE JEUNE, F. BLED, A. GIRAULT & P. FRESSINAUD. 1991. Small doses of ramipril to reduce microalbuminuria in diabetic patients with incipient nephropathy independently of blood pressure changes. J. Cardiovasc. Pharmacol. 18: S165-S168.
8. MATHIESON, E. R., E. HOMMEL, J. GIESE & H-H. PARVING. 1991. Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. Br. Med. J. 303: 81-87.
9. RAVID, M., H. SAVIN, I. JUTRIN, T. BENTAL, B. KATZ & M. LISIINER. 1993. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann. Intern. Med. 118: 577-581.
10. BARNETT, A. H., B. A. LEATHERDALE, A. POLAK, M. TOOP, K. WAKELIN, J. R. BRITTON, J. BENNETT, D. ROWE & K. DALLINGER. 1984. Specific thromboxane synthetase inhibition and albumin excretion rate in insulin-dependent diabetes. Lancet i: 1322-1324.
11. KONTESSIS, P. S., S. L. JONES, S. E. BARROW, P. D. STRATTON, P. ALESSANDRINI, S. DE COSMO, J. M. RITTER & G. C. VIBERTI. 1993. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy. J. Lab. Clin. Med. 121: 415-423.
12. SHINDO, H., M. TAWATA, N. YOKOMORI, Y. HOSAKA, M. OHTAKA & T. ONAYA. 1993. Iloprost decreases urinary albumin excretion rate in patients with diabetic nephropathy. Diabetes Res. Clin. Pract. 21: 115-122.
13. HAMAZAKI, T., E. TAKAZAKURA, K. OSAWA, M. URAKAZE & S. YANO. 1990. Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester. Lipids 25: 541-545.
14. DE CATERINA, R., S. ENDRES, S. D. KRISTENSEN & E. B. SCHMIDT. 1994. n-3 fatty acids and renal diseases. Am. J. Kidney Dis. 24: 397-415.
15. DE CATERINA, R., R. CAPRIOLI, D. GIANNESSI, R. SICARI, C. GALLI, G. LAZZERINI, W. BERNINI, L. CARR & P. RINDI. 1993. n-3 fatty acids reduce proteinuria in patients with chronic glomerular disease. Kidney Int. 44: 843-850.
16. DONADIO, J. V., JR., E. J. BERGSTRALH, K. P. OFFORD, D. C. SPENCER & K. E. HOLLEY. 1994. A controlled trial of fish oil in IgA nephropathy. N. Engl. J. Med. 331: 1194-1199.
17. ROSSING, P., B. V. HANSEN, F. S. NIELSEN, B. MYRUP & H.-H. PARVING. 1995. Fish oil in diabetic nephropathy (abstract). Eur. J. Endocrinol. 132(suppl. 1): 23.
18. JENSEN, T., S. STENDER, K. GOLDSTEIN, G. HOLMER & T. DECKERT. 1989. Partial normalization by dietary cod-liver oil of increased microvascular albumin leakage in patients with insulindependent diabetes and albuminuria. N. Engl. J. Med. 321: 1572-1577.
19. GLAUBER, H., P. WALLACE, K. GRIVER & G. BRECHTEL. 1988. Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitis. Ann. Intern. Med. 108: 663-668.
20. KASIM, S. E. 1993. Dietary marine fish oils and insulin action in type 2 diabetes. Ann. N.Y. Acad. Sci. 683: 250-257.
21. HARRIS, W. S. 1996. Do omega-3 fatty acids worsen glycemic control in NIDDM? ISSFAL Newsl. 3: 6-9.
22. HOWE, P. R. C. 1995. Can we recommend fish oil for hypertension? Clin. Exp. Pharmacol. Physiol. 22: 199-203.
23. MALASANOS, T. H. & P. W. STACPOOLE. 1991. Biological effects of omega-3 fatty acids in diabetes mellitus. Diabetes Care 14: 1160-1179.
24. MCLENNAN, P., P. HOWE, M. ABEYWARDENA, R. MUGGLI, D. RAEDERSTORFF, M. MANO, T. RAYNER & R. HEAD. 1996. The cardiovascular protective role of docosahexaenoic acid. Eur. J. Pharmacol. 300: 83-89.
25. MACKNESS, M. L, D. BHATNAGAR, P. N. DURRINGTON, H. PRAIS, B. HAYNES, J. MORGAN & L. BORTHWICK. 1994. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia. Eur. J. Clin. Nutr. 48: 859-865.
26. TOFT, I., K. H. BONAA, O. C. INGEBRETSEN, A. NORDOY & T. JENSSEN. 1995. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. Ann. Intern. Med. 123: 911-918.
27. BAKRIS, G. L. 1993. Hypertension in diabetic patients-an overview of interventional studies to preserve renal function. Am. J. Hypertens. 6: 140S-147S.
28. HOWE, P. R. C., Y. K. LUNGERSHAUSEN, L. COBIAC, G. DANDY & P. J. NESTEL. 1994. Effect of sodium restriction and fish oil supplementation on BP and thrombotic risk factors in patients treated with ACE inhibitors. J. Hum. Hypertens. 8: 43-49.